Nanocrystals

Nanocrystals

 

70% of drug molecules face problems of poor bioavailability and instability. Nanotechnology applied to medicine can provide important progress, often by improving bioavailability and dose optimization. Researchers propose here a new formulation excipient-free and based on nanocrystals, improving biodisponibility & dose efficacy. The first indication developed for this technology is a new formulation of Etoposide, a commonly used molecule to treat several cancers, which faces those problems and usual side effects.

 

Applications

  • Formulation of non-soluble drugs
  • Solid cancers such as Lung, ovarian, colorectal, breast
  • Acute myeloid leukemia

 

Competitive advantages

  • Low toxicity
  • Better biodisponibility
  • Better efficiency
  • Less administration
  • Suitable for different galenic forms

 

Intellectual property

  • International Patent Application in August 2019: EP2019/072873
  • Priority EU 08.2018, PCT 07.2019

 

Keywords

Drug formulation - Excipient-free - Biodisponibility - Etoposide - Cancer

Download the technology sheet

Everything is accelerating.
What about you?

Erganeo is at your disposal.

your topic
For any information concerning personal data, consult the legal notices.